Crohn'sNot yet recruiting
Qualitative Exploration of Key Symptoms of Stricturing Crohn's Disease: Toward the Development of a Clinical Assessment Score.
Observational · No treatment assigned · 1 site · University Hospital, Grenoble
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Crohn Disease (CD). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Adult patient (≥ 18 years old).
- With a confirmed diagnosis of Crohn's disease.
- Presenting a stricturing form of the disease (confirmed clinically, endoscopically, radiologically, or surgically).
Plus 3 more requirement(s). There are also 10 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 15 participants are expected to take part.
- Start date: 2026-05 (planned).
- Main results expected around 2026-09 (estimate from the record).
- 1 study site listed in France.
Main thing being measured
- Frequency of patient-reported symptom categories associated with stenosing Crohn's disease, derived from thematic content analysis of single semi-structured interviews. (Up to 5 months)
In the researchers’ words
The goal of this qualitative study is to identify and better understand the symptoms of stricturing Crohn's disease in order to inform the development of more appropriate clinical evaluation scores. This study focuses on adult patients diagnosed with stricturing Crohn's disease who are followed in hospital gastroenterology departments.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Crohn Disease (CD) |
| Lead sponsor | University Hospital, Grenoble |
| Enrollment | 15 (estimated) |
| Start date | 2026-05 |
| Primary completion (est.) | 2026-09 |
| First posted | 2026-03-02 |
| Last updated | 2026-05-20 |
| Official title | Qualitative Exploration of Key Symptoms of Stricturing Crohn's Disease: Toward the Development of a Clinical Assessment Score. |
| ClinicalTrials.gov ID | NCT07441629 |
Interventions
- Semi-structured interview (Other)
One-hour semi-structured interview in person or by videoconference. Interviews will be audio-recorded, pseudonymized, transcribed, and analyzed, and participants can review their transcripts before final anonymization.
Full eligibility criteria (from the record)
Inclusion Criteria: * Adult patient (≥ 18 years old). * With a confirmed diagnosis of Crohn's disease. * Presenting a stricturing form of the disease (confirmed clinically, endoscopically, radiologically, or surgically). * Followed in a hospital department managing inflammatory bowel diseases (IBD). * Clinically stable at the time of the interview (not experiencing an acute episode requiring urgent hospitalization). * Able to understand and speak French, in order to participate in a qualitative interview. Exclusion Criteria: * Current hospitalization for a severe Crohn's disease flare, acute intestinal obstruction, or any situation requiring urgent medical care. * Severe cognitive impairment, communication deficits, or acute psychiatric disorder preventing understanding of the interview or reliable expression of experiences. * Major uncontrolled medical comorbidity (e.g., active cancer under treatment, severe heart failure) making the interview inappropriate or likely to confound symptom interpretation. * Technical inability to participate in an interview (no access to the proposed modalities: unable to travel, no access to videoconference if a remote interview is required). * Pregnant women * Persons deprived of their liberty * Persons receiving psychiatric care * Persons admitted to a healthcare or social institution * Adults subject to a legal protection measure * Persons unable to express their consent
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Grenoble Alpes | La Tronche | France |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.